The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Asthma Medication-Global Market Insights and Sales Trends 2025
Synopsis
The global Asthma Medication market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Asthma Medication in various end use industries. The expanding demands from the Children, Adolescent and Adult,, are propelling Asthma Medication market. Quick-Relief Medications, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Long-Term Control Medications segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Asthma Medication, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Asthma Medication market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Asthma Medication market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Asthma Medication sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Asthma Medication covered in this report include Dulera, QVAR, Glaxosmithkline plc, MAP Pharmaceuticals，Inc, Merck & Co. Inc, AstraZeneca plc, Roche Holdings Ltd, Genentech Inc and Sepracor, Inc, etc.
The global Asthma Medication market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Dulera
QVAR
Glaxosmithkline plc
MAP Pharmaceuticals，Inc
Merck & Co. Inc
AstraZeneca plc
Roche Holdings Ltd
Genentech Inc
Sepracor, Inc
Schering-Plough Corp
Sanofi-Aventis
Theravance Inc
Global Asthma Medication market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Asthma Medication market, Segment by Type:
Quick-Relief Medications
Long-Term Control Medications
Asthma Medications During Pregnancy
Global Asthma Medication market, by Application
Children
Adolescent
Adult
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Asthma Medication manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Asthma Medication in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The global Asthma Medication market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Asthma Medication in various end use industries. The expanding demands from the Children, Adolescent and Adult,, are propelling Asthma Medication market. Quick-Relief Medications, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Long-Term Control Medications segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Asthma Medication, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Asthma Medication market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Asthma Medication market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Asthma Medication sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Asthma Medication covered in this report include Dulera, QVAR, Glaxosmithkline plc, MAP Pharmaceuticals，Inc, Merck & Co. Inc, AstraZeneca plc, Roche Holdings Ltd, Genentech Inc and Sepracor, Inc, etc.
The global Asthma Medication market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Dulera
QVAR
Glaxosmithkline plc
MAP Pharmaceuticals，Inc
Merck & Co. Inc
AstraZeneca plc
Roche Holdings Ltd
Genentech Inc
Sepracor, Inc
Schering-Plough Corp
Sanofi-Aventis
Theravance Inc
Global Asthma Medication market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Asthma Medication market, Segment by Type:
Quick-Relief Medications
Long-Term Control Medications
Asthma Medications During Pregnancy
Global Asthma Medication market, by Application
Children
Adolescent
Adult
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Asthma Medication manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Asthma Medication in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Asthma Medication Market Overview
1.1 Asthma Medication Product Overview
1.2 Asthma Medication Market Segment by Type
1.2.1 Quick-Relief Medications
1.2.2 Long-Term Control Medications
1.2.3 Asthma Medications During Pregnancy
1.3 Global Asthma Medication Market Size by Type
1.3.1 Global Asthma Medication Market Size Overview by Type (2018-2029)
1.3.2 Global Asthma Medication Historic Market Size Review by Type (2018-2023)
1.3.3 Global Asthma Medication Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Asthma Medication Sales Breakdown by Type (2018-2023)
1.4.2 Europe Asthma Medication Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Asthma Medication Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Asthma Medication Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Asthma Medication Sales Breakdown by Type (2018-2023)
2 Global Asthma Medication Market Competition by Company
2.1 Global Top Players by Asthma Medication Sales (2018-2023)
2.2 Global Top Players by Asthma Medication Revenue (2018-2023)
2.3 Global Top Players by Asthma Medication Price (2018-2023)
2.4 Global Top Manufacturers Asthma Medication Manufacturing Base Distribution, Sales Area, Product Type
2.5 Asthma Medication Market Competitive Situation and Trends
2.5.1 Asthma Medication Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Asthma Medication Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Asthma Medication as of 2022)
2.7 Date of Key Manufacturers Enter into Asthma Medication Market
2.8 Key Manufacturers Asthma Medication Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Asthma Medication Status and Outlook by Region
3.1 Global Asthma Medication Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Asthma Medication Historic Market Size by Region
3.2.1 Global Asthma Medication Sales in Volume by Region (2018-2023)
3.2.2 Global Asthma Medication Sales in Value by Region (2018-2023)
3.2.3 Global Asthma Medication Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Asthma Medication Forecasted Market Size by Region
3.3.1 Global Asthma Medication Sales in Volume by Region (2024-2029)
3.3.2 Global Asthma Medication Sales in Value by Region (2024-2029)
3.3.3 Global Asthma Medication Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Asthma Medication by Application
4.1 Asthma Medication Market Segment by Application
4.1.1 Children
4.1.2 Adolescent
4.1.3 Adult
4.2 Global Asthma Medication Market Size by Application
4.2.1 Global Asthma Medication Market Size Overview by Application (2018-2029)
4.2.2 Global Asthma Medication Historic Market Size Review by Application (2018-2023)
4.2.3 Global Asthma Medication Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Asthma Medication Sales Breakdown by Application (2018-2023)
4.3.2 Europe Asthma Medication Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Asthma Medication Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Asthma Medication Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Asthma Medication Sales Breakdown by Application (2018-2023)
5 North America Asthma Medication by Country
5.1 North America Asthma Medication Historic Market Size by Country
5.1.1 North America Asthma Medication Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Asthma Medication Sales in Volume by Country (2018-2023)
5.1.3 North America Asthma Medication Sales in Value by Country (2018-2023)
5.2 North America Asthma Medication Forecasted Market Size by Country
5.2.1 North America Asthma Medication Sales in Volume by Country (2024-2029)
5.2.2 North America Asthma Medication Sales in Value by Country (2024-2029)
6 Europe Asthma Medication by Country
6.1 Europe Asthma Medication Historic Market Size by Country
6.1.1 Europe Asthma Medication Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Asthma Medication Sales in Volume by Country (2018-2023)
6.1.3 Europe Asthma Medication Sales in Value by Country (2018-2023)
6.2 Europe Asthma Medication Forecasted Market Size by Country
6.2.1 Europe Asthma Medication Sales in Volume by Country (2024-2029)
6.2.2 Europe Asthma Medication Sales in Value by Country (2024-2029)
7 Asia-Pacific Asthma Medication by Region
7.1 Asia-Pacific Asthma Medication Historic Market Size by Region
7.1.1 Asia-Pacific Asthma Medication Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Asthma Medication Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Asthma Medication Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Asthma Medication Forecasted Market Size by Region
7.2.1 Asia-Pacific Asthma Medication Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Asthma Medication Sales in Value by Region (2024-2029)
8 Latin America Asthma Medication by Country
8.1 Latin America Asthma Medication Historic Market Size by Country
8.1.1 Latin America Asthma Medication Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Asthma Medication Sales in Volume by Country (2018-2023)
8.1.3 Latin America Asthma Medication Sales in Value by Country (2018-2023)
8.2 Latin America Asthma Medication Forecasted Market Size by Country
8.2.1 Latin America Asthma Medication Sales in Volume by Country (2024-2029)
8.2.2 Latin America Asthma Medication Sales in Value by Country (2024-2029)
9 Middle East and Africa Asthma Medication by Country
9.1 Middle East and Africa Asthma Medication Historic Market Size by Country
9.1.1 Middle East and Africa Asthma Medication Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Asthma Medication Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Asthma Medication Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Asthma Medication Forecasted Market Size by Country
9.2.1 Middle East and Africa Asthma Medication Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Asthma Medication Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Dulera
10.1.1 Dulera Company Information
10.1.2 Dulera Introduction and Business Overview
10.1.3 Dulera Asthma Medication Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Dulera Asthma Medication Products Offered
10.1.5 Dulera Recent Development
10.2 QVAR
10.2.1 QVAR Company Information
10.2.2 QVAR Introduction and Business Overview
10.2.3 QVAR Asthma Medication Sales, Revenue and Gross Margin (2018-2023)
10.2.4 QVAR Asthma Medication Products Offered
10.2.5 QVAR Recent Development
10.3 Glaxosmithkline plc
10.3.1 Glaxosmithkline plc Company Information
10.3.2 Glaxosmithkline plc Introduction and Business Overview
10.3.3 Glaxosmithkline plc Asthma Medication Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Glaxosmithkline plc Asthma Medication Products Offered
10.3.5 Glaxosmithkline plc Recent Development
10.4 MAP Pharmaceuticals，Inc
10.4.1 MAP Pharmaceuticals，Inc Company Information
10.4.2 MAP Pharmaceuticals，Inc Introduction and Business Overview
10.4.3 MAP Pharmaceuticals，Inc Asthma Medication Sales, Revenue and Gross Margin (2018-2023)
10.4.4 MAP Pharmaceuticals，Inc Asthma Medication Products Offered
10.4.5 MAP Pharmaceuticals，Inc Recent Development
10.5 Merck & Co. Inc
10.5.1 Merck & Co. Inc Company Information
10.5.2 Merck & Co. Inc Introduction and Business Overview
10.5.3 Merck & Co. Inc Asthma Medication Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Merck & Co. Inc Asthma Medication Products Offered
10.5.5 Merck & Co. Inc Recent Development
10.6 AstraZeneca plc
10.6.1 AstraZeneca plc Company Information
10.6.2 AstraZeneca plc Introduction and Business Overview
10.6.3 AstraZeneca plc Asthma Medication Sales, Revenue and Gross Margin (2018-2023)
10.6.4 AstraZeneca plc Asthma Medication Products Offered
10.6.5 AstraZeneca plc Recent Development
10.7 Roche Holdings Ltd
10.7.1 Roche Holdings Ltd Company Information
10.7.2 Roche Holdings Ltd Introduction and Business Overview
10.7.3 Roche Holdings Ltd Asthma Medication Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Roche Holdings Ltd Asthma Medication Products Offered
10.7.5 Roche Holdings Ltd Recent Development
10.8 Genentech Inc
10.8.1 Genentech Inc Company Information
10.8.2 Genentech Inc Introduction and Business Overview
10.8.3 Genentech Inc Asthma Medication Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Genentech Inc Asthma Medication Products Offered
10.8.5 Genentech Inc Recent Development
10.9 Sepracor, Inc
10.9.1 Sepracor, Inc Company Information
10.9.2 Sepracor, Inc Introduction and Business Overview
10.9.3 Sepracor, Inc Asthma Medication Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Sepracor, Inc Asthma Medication Products Offered
10.9.5 Sepracor, Inc Recent Development
10.10 Schering-Plough Corp
10.10.1 Schering-Plough Corp Company Information
10.10.2 Schering-Plough Corp Introduction and Business Overview
10.10.3 Schering-Plough Corp Asthma Medication Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Schering-Plough Corp Asthma Medication Products Offered
10.10.5 Schering-Plough Corp Recent Development
10.11 Sanofi-Aventis
10.11.1 Sanofi-Aventis Company Information
10.11.2 Sanofi-Aventis Introduction and Business Overview
10.11.3 Sanofi-Aventis Asthma Medication Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Sanofi-Aventis Asthma Medication Products Offered
10.11.5 Sanofi-Aventis Recent Development
10.12 Theravance Inc
10.12.1 Theravance Inc Company Information
10.12.2 Theravance Inc Introduction and Business Overview
10.12.3 Theravance Inc Asthma Medication Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Theravance Inc Asthma Medication Products Offered
10.12.5 Theravance Inc Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Asthma Medication Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Asthma Medication Industrial Chain Analysis
11.4 Asthma Medication Market Dynamics
11.4.1 Asthma Medication Industry Trends
11.4.2 Asthma Medication Market Drivers
11.4.3 Asthma Medication Market Challenges
11.4.4 Asthma Medication Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Asthma Medication Distributors
12.3 Asthma Medication Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
